Copyright © Inderes 2011 - present. All rights reserved.

Nexstim

14.30 EUR

-0.69 %

5,599 following

NXTMH

First North Finland

Medical Equipment & Services

Health Care

-0.69 %
+1.06 %
+13.04 %
+40.89 %
+81.01 %
+112.80 %
+241.29 %
+156.52 %
-97.64 %

Nexstim operates in medical technology. The company has developed a non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with 3D navigation providing targeting of the TMS to the specific area of the brain. The technology is aimed for the treatment of major depression and chronic neuropathic pain. The company was founded in 2000 and has its headquarters in Helsinki.

Read more
Market cap
103.15M EUR
Turnover
95.67K EUR
P/E (adj.) (25e)
25.31
EV/EBIT (adj.) (25e)
24.61
P/B (25e)
13.08
EV/S (25e)
6.67
Dividend yield-% (25e)
-
Coverage
Recommendation
Reduce
Target price
12.50 EUR
Updated
2025-08-18
Disclaimer
Antti Siltanen
Antti Siltanen

Analyst

Latest research

Latest analysis report

Released: 2025-08-18

Latest extensive report

Released: 2025-06-26

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
Based on announcements and my calculations, 31 machines have been delivered or ordered this year. Correct me if I calculated wrong. Regarding these speculations about the announcement and sales of diagnostic devices, the last deal that I believe could fall into the Brainlab category...
yesterday
by Jatast
28
Thank you @Jatast for your clarifying question. Regarding the communication of Brainlab equipment sales, we operate in accordance with our long-term partnership agreement. We aim to communicate these as distributor sales whenever possible, without revealing business secrets, meaning...
32 minutes ago
by Mikko Karvinen, Nexstim Oyj
25
It was not directly mentioned in the press release, but the only Finnish private operator that has had two old devices in use has been Recuror, which Terveystalo acquired last summer. So, Terveystalo will also continue with Nexstim devices, and now we await the expansion of treatment...
yesterday
by Kyhnykeisari
25
Oh wow, two devices for the day. We’ll get surprises for the advent calendar after all!
yesterday
by Apesor
21
Here is the announcement, gentlemen! nexstim.com Nexstim - Press-release
yesterday
by Umpi
18
Yep. I have strong confidence that this will still be a positive surprise in late winter. As long as the same trend continues until the end, that deals made by distributors in the Brainlab area are not announced. Brainlab has so many sellers and so many ready customers that it would...
20 hours ago
by MagnificRat
14
My theory is as follows: Terveystalo has now purchased two devices to update the NBS 5 devices that came with Recuror to the latest generation of devices, as their own staff will be trained at these two Terveystalo locations. It makes sense to update the devices used for training...
yesterday
by Kyhnykeisari
14
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.